Pyxis Oncology, Inc. (NASDAQ:PYXS) CEO Sells $17,936.10 in Stock etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
Hhlr Advisors LTD. Trims Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Pyxis Oncology (NASDAQ:PYXS – Get Free Report) posted its quarterly earnings results on Friday. The company reported ($0.41) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.65) by $0.24, MarketWatch Earnings reports. Pyxis Oncology Stock Up 6.6 % PYXS stock opened at $2.58 on Monday. The business has a 50 day moving […]
Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) shares shot up 3.5% on Monday . The stock traded as high as $2.66 and last traded at $2.65. 146,968 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 2,043,548 shares. The stock had previously closed at $2.56. Analyst Upgrades and […]
Pyxis Oncology (NASDAQ:PYXS – Free Report) and Rain Oncology (NASDAQ:RAIN – Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk. Profitability This table compares Pyxis Oncology and Rain Oncology’s […]